Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-26

Clinical Trial Update: Efficacy and Safety of Duloxetine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating duloxetine for urinary stress incontinence has completed, reporting efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Urinary Stress Incontinence | Phase 3 | Status: COMPLETED